About Hainan Haiyao Company

The company's predecessor, Haikou Pharmaceutical Factory, was founded in 1965 and listed on the Shenzhen Stock Exchange in 1994 (stock code: 000566). It is a leading enterprise in the pharmaceutical industry in Hainan Province. On March 24, 2020, Xinxing Jihua Pharmaceutical and Hainan Haiyao completed a strategic restructuring. Xinhaiyao became a mixed ownership enterprise controlled by a central enterprise, beginning a new journey of Haiyao development. The company focuses on health care, covering the fields of intermediates, APIs, chemical preparations, medical devices, modern traditional Chinese medicine, biomedicine and medical services. Currently, it mainly focuses on R&D, production and sales of pharmaceuticals and medical devices. The company's main products throughout the year include six major series, namely antibiotic series, gastrointestinal medication series, antineoplastic drug series, cochlear implant series, and formulation A set of APIs and intermediates and other products. Company Honors: High-tech Enterprise in Hainan Province; Vice Chairman's Unit; Top 50 Industrial Enterprises in Hainan; Top Ten Tax-Paying Enterprises, etc.